Renal hemodynamics in patients with resistant hypertension and type 2 diabetes mellitus

被引:0
|
作者
Manukyan, M. A. [1 ]
Yu, Falkovskaya A. [1 ]
Zyubanova, I., V [1 ]
Solonskaya, E., I [1 ]
Lichikaki, V. A. [1 ]
Ryabova, T. R. [1 ]
Vtorushina, A. A. [1 ]
Hunkhinova, S. A. [1 ]
Skomkina, I. A. [1 ]
Yevtukh, A. A. [1 ]
Gusakova, A. M. [1 ]
Mordovin, V. F. [1 ]
机构
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk Natl Res Ctr, Tomsk, Russia
关键词
Resistant arterial hypertension; type 2 diabetes mellitus; renal hemodynamics; renal arterial resistive index; CENTRAL PULSE PRESSURE; VASCULAR DAMAGE; ORGAN DAMAGE; INDEX; ULTRASOUND; ALBUMINURIA; POPULATION; STIFFNESS; PREDICTS;
D O I
10.18087/cardio.2023.8.n2468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To study renal hemodynamics in patients with resistant arterial hypertension (RAH) in combination with type 2 diabetes mellitus (DM2) and to identify factors involved in the increase in intrarenal vascular resistance. Material and methods This study included 59 patients (25 men) with RAH in combination with DM2. Mean age of patients was 60.3 +/- 7.9 years; 24-h blood pressure (24-BP) (systolic, diastolic, SBP /DBP) was 158.0 +/- 16.3/82.5 +/- 12.7 mm Hg during the treatment with 4.3 [4.0;5.0] antihypertensive drugs; glycated hemoglobin (HbA1c) was 7.5 +/- 1.5%; estimated glomerular filtration rate (eGFR) was 73.1 +/- 21.8 ml / min/ 1.73 m(2) (CKD-EPI equation). Measurement of office BP, 24-h BP monitoring, renal artery (RA) Doppler, routine lab tests including determination of GFR (CKD-EPI), 24-h urine albumin excretion, and ELISA measurement of blood lipocalin-2, cystatin C, high-sensitive C-reactive protein ( hsCRP), and asymmetric dimethylarginine (ADMA) were performed for all patients. Results Incidence of increased RA resistive index (RI) was 39 % despite the high rate of vasodilator treatment (93 % for renin-angiotensin-aldosterone system inhibitors, 78% for calcium antagonists). According to a correlation and regression analysis, RA RI values were correlated with the kidney function (r=-0.46, p<0.001 for eGFR, r=0.56; p=0.006 for lipocalin-2), age (r=0.54, p<0.001), increases in concentrations of hsCRP (r=0.35, p<0.001) and ADMA (r=0.39, p=0.028), the increase in vascular stiffness (r=0.59, p<0.001 for pulse BP (PBP) as well as DM2 duration, and HbA1c (r=0.33, p<0.001 for both). The independent association of RA RI with the age, PBP, and duration of DM2 was confirmed by the results of multivariate regression analysis. According to the ROC analysis, the threshold level of RA RI corresponding to a decrease in GFR <60 ml/min /1.73 m(2) was >= 0.693 conv. units. Conclusion In more than one third of patients with RAH in combination with DM2, increased renal vascular resistance was documented, which was closely associated with impaired kidney function, age, DM2 duration and severity, and markers of low-grade inflammation, endothelial dysfunction, and vascular stiffness. The value of RA RI >= 0.693 conv. units was a threshold for the development of chronic kidney disease (CKD).
引用
收藏
页码:42 / 49
页数:7
相关论文
共 50 条
  • [31] Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
    Viazzi, Francesca
    Piscitelli, Pamela
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
  • [32] THE THERAPY OF MICROALBUMINURIC PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION
    Fu Xin
    Huang Zhenwen
    HEART, 2011, 97 : A230 - A230
  • [33] CARDIAC REMODELING IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION
    Krutikov, Ye S.
    Tsvetkov, V. A.
    Chistyakova, S., I
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 4 - 9
  • [34] Hypertension in patients with type 2 diabetes mellitus: Targets and management
    Pavlou, Dimitra, I
    Paschou, Stavroula A.
    Anagnostis, Panagiotis
    Spartalis, Michael
    Spartalis, Eleftherios
    Vryonidou, Andromachi
    Tentolouris, Nicholas
    Siasos, Gerasimos
    MATURITAS, 2018, 112 : 71 - 77
  • [35] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    BLOOD PRESSURE, 2000, 9 (06) : 363 - 364
  • [36] Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
    Cruz, Misma Silva
    Ferreira da Silva, Ingrid Cristina
    Goncalves Miguez, Jessica Silva
    Rocha Machado, Mariana Pirani
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [37] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    JOURNAL OF HYPERTENSION, 2000, 18 (09) : 1345 - 1346
  • [38] MRI OF THE ARTERIAL WALL IN RESISTANT HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS
    Ryumshina, Nadezhda, I
    Falkovskaya, Alla Y.
    Gusakova, Anna M.
    Mordovin, Victor F.
    Usov, Vladimir Y.
    DIABETES MELLITUS, 2020, 23 (01): : 29 - 36
  • [39] Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function
    Falkovskaya, A. Yu
    Mordovin, V. F.
    Pekarskiy, S. E.
    Ripp, T. M.
    Manukyan, M. A.
    Lichikaki, V. A.
    Zyubanova, I., V
    Sitkova, E. S.
    Gusakova, A. M.
    Ryabova, T. R.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (01) : 49 - 58
  • [40] Effects of Dapagliflozin Therapy on Renal Hemodynamics in Type 2 Diabetes Patients
    Qin, Yuejuan
    Baskoy, Gozde
    Triplitt, Curtis L.
    Solis-Herrera, Carolina
    Adams, John M., III
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2023, 72